LHX2
Basic information
Region (hg38): 9:124001670-124033301
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the LHX2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 4 | |||||
missense | 14 | 16 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 3 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 1 | 16 | 4 | 2 |
Variants in LHX2
This is a list of pathogenic ClinVar variants found in the LHX2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
9-124012409-A-G | not specified | Uncertain significance (Feb 17, 2023) | ||
9-124012420-C-G | not specified | Uncertain significance (Aug 28, 2023) | ||
9-124012460-A-G | not specified | Uncertain significance (Jun 29, 2023) | ||
9-124013973-A-G | not specified | Uncertain significance (Feb 05, 2024) | ||
9-124013976-AGCAGTGACCGC-A | Uncertain significance (Nov 21, 2022) | |||
9-124014022-CGGACC-ACCT | Variable neurodevelopmental disorder | Likely pathogenic (Apr 14, 2023) | ||
9-124014127-AGGACG-A | Pathogenic (Aug 07, 2023) | |||
9-124014131-C-T | LHX2-related disorder | Likely benign (Aug 15, 2019) | ||
9-124015138-C-A | not specified | Uncertain significance (Oct 04, 2022) | ||
9-124015149-C-T | LHX2-related disorder | Likely benign (Jan 03, 2020) | ||
9-124015235-G-A | Pathogenic (Aug 07, 2023) | |||
9-124015258-G-C | Uncertain significance (Jun 27, 2024) | |||
9-124015273-A-T | Uncertain significance (Apr 11, 2023) | |||
9-124015279-A-G | not specified | Uncertain significance (Mar 25, 2024) | ||
9-124015305-C-A | not specified | Uncertain significance (May 10, 2024) | ||
9-124015353-C-CG | Uncertain significance (Apr 09, 2023) | |||
9-124015376-C-T | not specified | Uncertain significance (Apr 20, 2023) | ||
9-124015379-C-G | not specified | Uncertain significance (Jun 23, 2023) | ||
9-124015381-G-C | not specified | Uncertain significance (Feb 15, 2023) | ||
9-124015447-G-A | LHX2-related disorder | Benign (Oct 28, 2019) | ||
9-124015502-C-T | not specified | Uncertain significance (Sep 29, 2023) | ||
9-124021099-C-T | not specified | Uncertain significance (Apr 10, 2023) | ||
9-124021113-G-A | not specified | Uncertain significance (Dec 08, 2023) | ||
9-124021136-C-T | LHX2-related disorder | Benign (Jul 27, 2018) | ||
9-124021147-C-A | LHX2-related disorder | Likely benign (Mar 28, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
LHX2 | protein_coding | protein_coding | ENST00000373615 | 5 | 31632 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.988 | 0.0119 | 0 | 0 | 0 | 0 | 0.00 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.27 | 143 | 243 | 0.589 | 0.0000126 | 2638 |
Missense in Polyphen | 47 | 102.86 | 0.45692 | 1060 | ||
Synonymous | -1.17 | 121 | 106 | 1.14 | 0.00000563 | 818 |
Loss of Function | 3.39 | 0 | 13.4 | 0.00 | 6.23e-7 | 161 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Acts as a transcriptional activator. Stimulates the promoter of the alpha-glycoprotein gene. Transcriptional regulatory protein involved in the control of cell differentiation in developing lymphoid and neural cell types (By similarity). {ECO:0000250}.;
- Pathway
- Neural Crest Differentiation;Developmental Biology;Regulation of expression of SLITs and ROBOs;Signaling by ROBO receptors;Axon guidance
(Consensus)
Recessive Scores
- pRec
- 0.238
Intolerance Scores
- loftool
- rvis_EVS
- -0.12
- rvis_percentile_EVS
- 44.89
Haploinsufficiency Scores
- pHI
- 0.992
- hipred
- Y
- hipred_score
- 0.875
- ghis
- 0.517
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.926
Mouse Genome Informatics
- Gene name
- Lhx2
- Phenotype
- craniofacial phenotype; homeostasis/metabolism phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; hematopoietic system phenotype; taste/olfaction phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype; liver/biliary system phenotype; respiratory system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Zebrafish Information Network
- Gene name
- lhx2b
- Affected structure
- retinal ganglion cell
- Phenotype tag
- abnormal
- Phenotype quality
- misrouted
Gene ontology
- Biological process
- neural tube closure;hair follicle development;axon guidance;mesoderm development;dorsal/ventral pattern formation;olfactory bulb development;telencephalon regionalization;cerebral cortex development;maintenance of epithelial cell apical/basal polarity;negative regulation of gene expression, epigenetic;positive regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II;axon extension;negative regulation of neurogenesis;retina development in camera-type eye;positive regulation of neural precursor cell proliferation;negative regulation of transcription regulatory region DNA binding
- Cellular component
- nucleus
- Molecular function
- RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;chromatin binding;metal ion binding